In particular, there is interest in utilising MRS to differentiate the primary astrocytopathy Aquaporin-4 Antibody positive Neuromyelitis Optica Spectrum Disorders (AQP4Ab-NMOSD) (Fujihara, 2011) from the clinically similar but pathologically distinct disorder, Multiple Sclerosis (MS), which is believed to be a chronic inflammatory demyelinating disorder with secondary neurodegeneration (Lucchinetti et al., 2014; Wingerchuk et al., 2015). This evidence concerns the gene AQP4 and neuromyelitis optica.